Fundraising FoxBroadOak Capital Partners — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
seqWellseqwell.comin𝕏Mar 2022
seqWell develops reagents and technologies for next-generation sequencing library preparation, serving academic and institutional research clients.
BiotechDeep TechBeverly, US
Thomas Grant(Executive Officer)inDaniel Calvo(Executive Officer, Director)JoeJackJoseph Mellor(Executive Officer, Director)Joseph Mellor, Ph.D.(Executive Officer, Director)
Co-investorsResearch Corporation Technologies
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.